
Gain Therapeutics, Inc.
Gain Therapeutics, Inc. (GANX)
WebsitePrice
Market cap
Next catalystQ1 2027 initiation, following a comprehensive redesign and submission of new Phase 2 protocolRexaceract — planned Phase 2a early Parkinson’s disease study · Trial initiationCompany release ↗
Cash